<h4>Objective</h4>Prolactin (PRL) is increasingly recognized as a pleiotropic hormone with potent immunoregulatory properties; however, its involvement in systemic inflammation among diabetic kidney disease (DKD) patients has not been defined. The gene discussed is PRL; the disease is diabetic kidney disease.